TGFB1 and hepatocellular carcinoma: The GSEA results of the high-TGF-β1/high-TG2 and low-TGF-β1/low-TG2 HCC groups also highlighted inflammation signaling and response, suggesting that TGF-β1-dependent TG2 activation overly enhances the inflammatory response, which probably plays a role in the clinical outcome.